Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients

Hsu YC, Lin JT, Ho HJ, Kao YH, Huang YT, Hsiao NW, et al. Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients. Hepatology. 2014;59(4):1293-1302.

Publication Type:

Journal Article

Authors:

Hsu, Y.C.; Lin, J.T.; Ho, H.J.; Kao, Y.H.; Huang, Y.T.; Hsiao, N.W.; Wu, M.S.; Liu, Y.Y.; Wu, C.Y.

Source:

Hepatology, Volume 59, Issue 4, p.1293-1302 (2014)

Keywords:

Acute Coronary Syndrome, Adult, Aged, Antibodies, Antiviral Agents, China, clinical trial, Cohort Studies, Comorbidity, Diabetes Mellitus, diagnosis, Disease, drug therapy, Drug Therapy,Combination, epidemiology, Female, Follow-Up Studies, Gastroenterology, HCV, Health, hepatitis, Hepatitis C, hepatitis C virus, Humans, Incidence, Infection, Insulin, Insulin Resistance, interferon, Interferon-alpha, Kidney Failure,Chronic, Male, Medicine, Middle Aged, Multivariate Analysis, Patients, peginterferon, pegylated, pegylated interferon, Polyethylene Glycols, prevention & control, Proteins, Recombinant Proteins, Renal, Research, Research Support, resistance, Ribavirin, Risk Factors, Serum, Stroke, Syndrome, Taiwan, therapeutic use, therapy, treatment, Treatment Outcome

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/24122848

Export Citation:

RIS Format

Top